Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1207-69-8

Post Buying Request

1207-69-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1207-69-8 Usage

Chemical Properties

Green to brown solid

Uses

9-Chloroacridine was employed as chromogenic reagent in the spectrophotometric method for the quantitative determination of dapsone. It was also used in the synthesis of:series of novel chalcones bearing acridine moiety attached to the amino group in their ring Anew acridine derivatives9-phenoxyacridine and 4-phenoxyfuro[2,3-b]quinoline derivatives

Check Digit Verification of cas no

The CAS Registry Mumber 1207-69-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,2,0 and 7 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1207-69:
(6*1)+(5*2)+(4*0)+(3*7)+(2*6)+(1*9)=58
58 % 10 = 8
So 1207-69-8 is a valid CAS Registry Number.
InChI:InChI=1/C13H8ClN/c14-13-9-5-1-3-7-11(9)15-12-8-4-2-6-10(12)13/h1-8H

1207-69-8 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (159425)  9-Chloroacridine  97%

  • 1207-69-8

  • 159425-1G

  • 756.99CNY

  • Detail
  • Aldrich

  • (159425)  9-Chloroacridine  97%

  • 1207-69-8

  • 159425-5G

  • 2,472.21CNY

  • Detail

1207-69-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 9-Chloroacridine

1.2 Other means of identification

Product number -
Other names Acridine, 9-chloro-

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1207-69-8 SDS

1207-69-8Synthetic route

10H-acridin-9-one
578-95-0

10H-acridin-9-one

9-Chloroacridine
1207-69-8

9-Chloroacridine

Conditions
ConditionsYield
With thionyl chloride In N,N-dimethyl-formamide at 80℃; for 3h; Inert atmosphere;99%
With thionyl chloride; N,N-dimethyl-formamide for 0.5h; Chlorination; Heating;96%
With trichlorophosphate for 1h; Heating;91%
2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

9-Chloroacridine
1207-69-8

9-Chloroacridine

Conditions
ConditionsYield
With trichlorophosphate at 100℃; for 0.025h; Microwave irradiation;98%
With trichlorophosphate at 135 - 140℃; for 2h; Inert atmosphere;96%
With sulfuric acid; trichlorophosphate for 12h; Heating;84%
aniline
62-53-3

aniline

ortho-chlorobenzoic acid
118-91-2

ortho-chlorobenzoic acid

9-Chloroacridine
1207-69-8

9-Chloroacridine

Conditions
ConditionsYield
Stage #1: aniline; ortho-chlorobenzoic acid With copper; potassium carbonate Ullmann Condensation; Reflux;
Stage #2: With trichlorophosphate Reflux;
60%
With trichlorophosphate Multistep reaction;
Multi-step reaction with 2 steps
1: copper; potassium carbonate / N,N-dimethyl-formamide / Heating
2: trichlorophosphate / 0.25 h / 140 °C / Microwave irradiation
View Scheme
acridine
260-94-6

acridine

9-Chloroacridine
1207-69-8

9-Chloroacridine

Conditions
ConditionsYield
With disulfur dichloride at 130 - 180℃;
Multi-step reaction with 2 steps
1: chromium acetic acid / bei der Oxydation
2: phosphorus oxychloride; phosphorus pentachloride / 120 - 130 °C
View Scheme
Multi-step reaction with 2 steps
1: sulfur
2: phosphorus oxychloride; phosphorus pentachloride / 120 - 130 °C
View Scheme
With hydrogenchloride In ethanol at 4℃;
acridine-9-thione
6540-78-9

acridine-9-thione

9-Chloroacridine
1207-69-8

9-Chloroacridine

Conditions
ConditionsYield
With phosphorus pentachloride; trichlorophosphate at 120 - 130℃;
Multi-step reaction with 3 steps
1: bromine; red phosphorus
2: diluted alcohol; sodium sulfide
3: phosphorus pentachloride
View Scheme
Multi-step reaction with 3 steps
1: phosphorus; bromine
2: diluted alcohol; sodium sulfide
3: phosphorus pentachloride
View Scheme
With phosphorus pentachloride; trichlorophosphate at 120 - 130℃;
acridine-9-thione
6540-78-9

acridine-9-thione

A

9-Chloroacridine
1207-69-8

9-Chloroacridine

B

9,9'-diacridinyl sulfide
85842-89-3

9,9'-diacridinyl sulfide

Conditions
ConditionsYield
With phosphorus pentachloride
acridine-9-thione
6540-78-9

acridine-9-thione

phosphorus pentachloride
10026-13-8, 874483-75-7

phosphorus pentachloride

9-Chloroacridine
1207-69-8

9-Chloroacridine

phosphorus pentachloride
10026-13-8, 874483-75-7

phosphorus pentachloride

10H-acridin-9-one
578-95-0

10H-acridin-9-one

9-Chloroacridine
1207-69-8

9-Chloroacridine

Conditions
ConditionsYield
at 120 - 130℃;
acridine
260-94-6

acridine

disulfur dichloride

disulfur dichloride

9-Chloroacridine
1207-69-8

9-Chloroacridine

Conditions
ConditionsYield
at 130 - 180℃;
N-oxy-acridone

N-oxy-acridone

9-Chloroacridine
1207-69-8

9-Chloroacridine

Conditions
ConditionsYield
nach Reduktion beim Erhitzen mit Phophorpentachlorid und wenig Phosphoroxychlorid auf 120-130grad;
acridine-9-thione
6540-78-9

acridine-9-thione

phosphorus pentachloride
10026-13-8, 874483-75-7

phosphorus pentachloride

A

9-Chloroacridine
1207-69-8

9-Chloroacridine

B

di--sulfide

di--sulfide

2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

9-Chloroacridine
1207-69-8

9-Chloroacridine

2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

phosphorus pentachloride
10026-13-8, 874483-75-7

phosphorus pentachloride

benzene
71-43-2

benzene

9-Chloroacridine
1207-69-8

9-Chloroacridine

Conditions
ConditionsYield
Erhitzen des vom Benzol befreiten Reaktionsgemisches auf 140grad;
9-bromoacridine
4357-57-7

9-bromoacridine

9-Chloroacridine
1207-69-8

9-Chloroacridine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: diluted alcohol; sodium sulfide
2: phosphorus pentachloride
View Scheme
ortho-chlorobenzoic acid
118-91-2

ortho-chlorobenzoic acid

9-Chloroacridine
1207-69-8

9-Chloroacridine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: potassium carbonate; copper(II) oxide / 2 h / Reflux
2: trichlorophosphate / 0.05 h / Microwave irradiation
View Scheme
Multi-step reaction with 2 steps
1: potassium carbonate; copper / N,N-dimethyl-formamide / 130 °C
2: trichlorophosphate / 3 h / 130 °C
View Scheme
Multi-step reaction with 2 steps
1: copper; potassium carbonate / 2-ethoxy-ethanol / 8 h / Reflux
2: trichlorophosphate / 6 h / Reflux
View Scheme
aniline
62-53-3

aniline

9-Chloroacridine
1207-69-8

9-Chloroacridine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: potassium carbonate; copper(II) oxide / 2 h / Reflux
2: trichlorophosphate / 0.05 h / Microwave irradiation
View Scheme
Multi-step reaction with 2 steps
1: potassium carbonate; copper / N,N-dimethyl-formamide / 130 °C
2: trichlorophosphate / 3 h / 130 °C
View Scheme
Multi-step reaction with 2 steps
1: copper; potassium carbonate / 2-ethoxy-ethanol / 8 h / Reflux
2: trichlorophosphate / 6 h / Reflux
View Scheme
2-bromobenzoic-acid
88-65-3

2-bromobenzoic-acid

9-Chloroacridine
1207-69-8

9-Chloroacridine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: copper; potassium carbonate / ethanol / 80 °C
2: sulfuric acid / 100 °C
3: trichlorophosphate / 110 °C
View Scheme
benzoic acid
65-85-0

benzoic acid

9-Chloroacridine
1207-69-8

9-Chloroacridine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: potassium iodide; copper; potassium carbonate / N,N-dimethyl-formamide / Reflux
2: trichlorophosphate / 135 °C
View Scheme
anthranilic acid
118-92-3

anthranilic acid

9-Chloroacridine
1207-69-8

9-Chloroacridine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: potassium carbonate; copper; copper(l) iodide / N,N-dimethyl-formamide / 12 h / 120 °C / Inert atmosphere
2: sulfuric acid / 2 h / 100 °C / Inert atmosphere
3: trichlorophosphate / N,N-dimethyl-formamide / 3 h / 0 - 100 °C
View Scheme
bromobenzene
108-86-1

bromobenzene

9-Chloroacridine
1207-69-8

9-Chloroacridine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: potassium carbonate; copper; copper(l) iodide / N,N-dimethyl-formamide / 12 h / 120 °C / Inert atmosphere
2: sulfuric acid / 2 h / 100 °C / Inert atmosphere
3: trichlorophosphate / N,N-dimethyl-formamide / 3 h / 0 - 100 °C
View Scheme
9-Chloroacridine
1207-69-8

9-Chloroacridine

5-(3-aminopropoxy)-N1,N3-bis(3-{[(6-{[[di(2-pyridinyl)methyl](2-pyridinylmethyl)amino]methyl}-3-pyridinyl)carbonyl]amino}propyl)isophthalamide
1141722-29-3

5-(3-aminopropoxy)-N1,N3-bis(3-{[(6-{[[di(2-pyridinyl)methyl](2-pyridinylmethyl)amino]methyl}-3-pyridinyl)carbonyl]amino}propyl)isophthalamide

C78H74N16O5*ClH
1141722-15-7

C78H74N16O5*ClH

Conditions
ConditionsYield
With phenol at 80℃; for 3h;100%
9-Chloroacridine
1207-69-8

9-Chloroacridine

potassium cyanide
151-50-8

potassium cyanide

acridine-9-carbonitrile
5326-19-2

acridine-9-carbonitrile

Conditions
ConditionsYield
With sodium 4-methylbenzenesulfinate In N,N-dimethyl-formamide at 60℃; for 1h;99.5%
9-Chloroacridine
1207-69-8

9-Chloroacridine

phenol
108-95-2

phenol

9-phenoxyacridine
2148-14-3

9-phenoxyacridine

Conditions
ConditionsYield
With sodium hydroxide for 18h; Substitution; Heating;99%
With sodium hydroxide at 100℃; for 1.5h;97.9%
With potassium carbonate In N,N-dimethyl-formamide at 100 - 110℃; for 24h;94%
9-Chloroacridine
1207-69-8

9-Chloroacridine

phenylboronic acid
98-80-6

phenylboronic acid

9-phenylacridine
602-56-2

9-phenylacridine

Conditions
ConditionsYield
With potassium phosphate In toluene at 100℃; for 24h; Catalytic behavior; Reagent/catalyst; Solvent; Time; Temperature; Suzuki-Miyaura Coupling; Schlenk technique; Inert atmosphere;99%
With tetrakis(triphenylphosphine) palladium(0); sodium carbonate In water; toluene at 40℃; for 3h;96.8%
With tetrakis(triphenylphosphine) palladium(0); potassium carbonate In 1,2-dimethoxyethane; ethanol; water at 90℃; for 24h; Inert atmosphere;87%
With palladium(II) acetate bis(diphenylphosphino)ferrocene; sodium carbonate In N,N-dimethyl-formamide at 100 - 110℃; for 16h; Phenylation;60%
With potassium phosphate; palladium diacetate; tricyclohexylphosphine In water; toluene Reflux;
9-Chloroacridine
1207-69-8

9-Chloroacridine

N-(3-aminopropyl)-6-(((di-pyridin-2-yl-methyl)pyridin-2-ylmethylamino)methyl)nicotinamide
321907-45-3

N-(3-aminopropyl)-6-(((di-pyridin-2-yl-methyl)pyridin-2-ylmethylamino)methyl)nicotinamide

N-[3-(acridin-9-ylamino)-propyl]-6-{[(di-pyridin-2-yl-methyl)-pyridin-2-ylmethyl-amino]-methyl}-nicotinamide

N-[3-(acridin-9-ylamino)-propyl]-6-{[(di-pyridin-2-yl-methyl)-pyridin-2-ylmethyl-amino]-methyl}-nicotinamide

Conditions
ConditionsYield
With phenol99%
9-Chloroacridine
1207-69-8

9-Chloroacridine

2-(3-aminopropoxy)-N1,N3-bis[3-(6-{[(dipyridin-2ylmethyl)(pyridin-2ylmethyl)amino]methyl}-nicotinamido)propyl]isophthalamide
1141722-31-7

2-(3-aminopropoxy)-N1,N3-bis[3-(6-{[(dipyridin-2ylmethyl)(pyridin-2ylmethyl)amino]methyl}-nicotinamido)propyl]isophthalamide

C78H74N16O5*ClH
1141722-16-8

C78H74N16O5*ClH

Conditions
ConditionsYield
With phenol at 80℃; for 3h;99%
9-Chloroacridine
1207-69-8

9-Chloroacridine

2-Methylphenylboronic acid
16419-60-6

2-Methylphenylboronic acid

9-(2-methylphenyl)acridine
40333-47-9

9-(2-methylphenyl)acridine

Conditions
ConditionsYield
With potassium phosphate In toluene at 100℃; for 24h; Suzuki-Miyaura Coupling; Schlenk technique; Inert atmosphere;99%
With potassium phosphate monohydrate; 9-(2-(dicyclohexylphosphino)phenyl)-9H-carbazole; palladium diacetate; phenylboronic acid In 1,4-dioxane at 110℃; for 24h; Suzuki coupling; Inert atmosphere;92%
9-Chloroacridine
1207-69-8

9-Chloroacridine

naphthalene-2-boronic acid
32316-92-0

naphthalene-2-boronic acid

9-(naphthalen-2-yl)acridine

9-(naphthalen-2-yl)acridine

Conditions
ConditionsYield
With potassium phosphate In toluene at 100℃; for 24h; Suzuki-Miyaura Coupling; Schlenk technique; Inert atmosphere;99%
With potassium phosphate; palladium diacetate; tricyclohexylphosphine In water; toluene Reflux;
9-Chloroacridine
1207-69-8

9-Chloroacridine

4-methoxyphenylboronic acid
5720-07-0

4-methoxyphenylboronic acid

9-(4-methoxyphenyl)acridine
21164-57-8

9-(4-methoxyphenyl)acridine

Conditions
ConditionsYield
With potassium phosphate In toluene at 100℃; for 24h; Suzuki-Miyaura Coupling; Schlenk technique; Inert atmosphere;99%
With potassium phosphate; palladium diacetate; tricyclohexylphosphine In water; toluene Reflux;
9-Chloroacridine
1207-69-8

9-Chloroacridine

3,5-dimethylphenyl boronic acid
172975-69-8

3,5-dimethylphenyl boronic acid

9-(3,5-dimethylphenyl)acridine
1352136-18-5

9-(3,5-dimethylphenyl)acridine

Conditions
ConditionsYield
With potassium phosphate In toluene at 100℃; for 24h; Suzuki-Miyaura Coupling; Schlenk technique; Inert atmosphere;99%
With potassium phosphate; palladium diacetate; tricyclohexylphosphine In water; toluene Reflux;
9-Chloroacridine
1207-69-8

9-Chloroacridine

m-tolylboronic acid
17933-03-8

m-tolylboronic acid

9-(m-tolyl)acridine

9-(m-tolyl)acridine

Conditions
ConditionsYield
With potassium phosphate In toluene at 100℃; for 24h; Suzuki-Miyaura Coupling; Schlenk technique; Inert atmosphere;99%
With palladium diacetate; sodium carbonate In water; toluene at 40℃; for 3h;96.9%
9-Chloroacridine
1207-69-8

9-Chloroacridine

4-methylphenylboronic acid
5720-05-8

4-methylphenylboronic acid

9-(4-methylphenyl)acridine
36388-29-1

9-(4-methylphenyl)acridine

Conditions
ConditionsYield
With potassium phosphate In toluene at 100℃; for 24h; Suzuki-Miyaura Coupling; Schlenk technique; Inert atmosphere;99%
With potassium phosphate; tris-(dibenzylideneacetone)dipalladium(0); 3-(dicyclohexylphosphino)-2-(2,6-dimethoxyphenyl)-1-methyl-1H-indole In 1,4-dioxane at 100℃; for 2h; Suzuki-Miyaura Coupling; Schlenk technique; Sealed tube; Inert atmosphere;93%
9-Chloroacridine
1207-69-8

9-Chloroacridine

4-tert-butylphenylboronic acid
123324-71-0

4-tert-butylphenylboronic acid

9-(4-(tert-butyl)phenyl)acridine

9-(4-(tert-butyl)phenyl)acridine

Conditions
ConditionsYield
With potassium phosphate In toluene at 100℃; for 24h; Suzuki-Miyaura Coupling; Schlenk technique; Inert atmosphere;99%
9-Chloroacridine
1207-69-8

9-Chloroacridine

4-fluoroboronic acid
1765-93-1

4-fluoroboronic acid

9-(4-fluorophenyl)acridine

9-(4-fluorophenyl)acridine

Conditions
ConditionsYield
With potassium phosphate In toluene at 100℃; for 24h; Suzuki-Miyaura Coupling; Schlenk technique; Inert atmosphere;99%
9-Chloroacridine
1207-69-8

9-Chloroacridine

4-trifluoromethylphenylboronic acid
128796-39-4

4-trifluoromethylphenylboronic acid

9-(4-(trifluoromethyl)phenyl)acridine

9-(4-(trifluoromethyl)phenyl)acridine

Conditions
ConditionsYield
With potassium phosphate In toluene at 100℃; for 24h; Suzuki-Miyaura Coupling; Schlenk technique; Inert atmosphere;99%
With tetrakis(triphenylphosphine) palladium(0); potassium carbonate In 1,4-dioxane; water at 165℃; for 0.25h; Inert atmosphere; Microwave irradiation;
9-Chloroacridine
1207-69-8

9-Chloroacridine

1-Naphthylboronic acid
13922-41-3

1-Naphthylboronic acid

9-(naphthalen-1-yl)acridine
474452-91-0

9-(naphthalen-1-yl)acridine

Conditions
ConditionsYield
With potassium phosphate In toluene at 100℃; for 24h; Suzuki-Miyaura Coupling; Schlenk technique; Inert atmosphere;99%
9-Chloroacridine
1207-69-8

9-Chloroacridine

cyclopropylboronic acid
411235-57-9

cyclopropylboronic acid

C16H13N

C16H13N

Conditions
ConditionsYield
With potassium phosphate In toluene at 100℃; for 24h; Suzuki-Miyaura Coupling; Schlenk technique; Inert atmosphere;99%
9-Chloroacridine
1207-69-8

9-Chloroacridine

(2-phenylethyl)boronic acid
34420-17-2

(2-phenylethyl)boronic acid

9-phenethyl-acridine
29162-11-6

9-phenethyl-acridine

Conditions
ConditionsYield
With potassium phosphate In toluene at 100℃; for 24h; Suzuki-Miyaura Coupling; Schlenk technique; Inert atmosphere;99%
9-Chloroacridine
1207-69-8

9-Chloroacridine

α-(2-chlorophenoxy)butanoylhydrazine

α-(2-chlorophenoxy)butanoylhydrazine

N-acridin-5-yl-N'-α-(2-chlorophenoxy)butanoylhydrazine

N-acridin-5-yl-N'-α-(2-chlorophenoxy)butanoylhydrazine

Conditions
ConditionsYield
In methanol for 3h; Heating;98.5%
1,4-bis(3-aminopropyl)piperazine
7209-38-3

1,4-bis(3-aminopropyl)piperazine

9-Chloroacridine
1207-69-8

9-Chloroacridine

C36H38N6*4ClH
86689-09-0

C36H38N6*4ClH

Conditions
ConditionsYield
With phenol98%
9-Chloroacridine
1207-69-8

9-Chloroacridine

4-Hydroxyacetophenone
99-93-4

4-Hydroxyacetophenone

1-[4-(acridin-9-yloxy)-phenyl]-ethanone

1-[4-(acridin-9-yloxy)-phenyl]-ethanone

Conditions
ConditionsYield
With potassium carbonate In acetone at 150℃; for 20h;98%
9-Chloroacridine
1207-69-8

9-Chloroacridine

α-(4-chlorophenoxy)butanoylhydrazine

α-(4-chlorophenoxy)butanoylhydrazine

N-acridin-5-yl-N'-α-(4-chlorophenoxy)butanoylhydrazine

N-acridin-5-yl-N'-α-(4-chlorophenoxy)butanoylhydrazine

Conditions
ConditionsYield
In methanol for 3h; Heating;97.6%
1-methyl-1H-imidazole
616-47-7

1-methyl-1H-imidazole

9-Chloroacridine
1207-69-8

9-Chloroacridine

C17H14N3(1+)*Cl(1-)
1402413-62-0

C17H14N3(1+)*Cl(1-)

Conditions
ConditionsYield
In toluene at 140℃; for 12h;97.6%
9-Chloroacridine
1207-69-8

9-Chloroacridine

3-isopropylphenylboronic acid
216019-28-2

3-isopropylphenylboronic acid

C22H19N

C22H19N

Conditions
ConditionsYield
With [1,4-bis(diphenylphosphino)butane] palladium(ll) dichloride; sodium carbonate In water; toluene at 60℃; for 5h;97.3%
9-Chloroacridine
1207-69-8

9-Chloroacridine

(3-ethynylphenyl)boronic acid

(3-ethynylphenyl)boronic acid

C21H13N

C21H13N

Conditions
ConditionsYield
With bis(triphenylphosphine)palladium(II) dichloride; sodium carbonate In water; toluene at 50℃; for 4h;97.1%

1207-69-8Related news

Determination of Sulfonamides and Local Anesthetics with 9-Chloroacridine (cas 1207-69-8) by Quenching Fluorometry07/21/2019

Sulfonamides and local anesthetics containing a primary aromatic amino group react with 9-chloroacridine to yield aminoacridine hydrochlorides. The formation of these derivatives results in quenching of fluorescence of the 9-chloroacridine reagent solution. Monitoring the fluorescence at activat...detailed

1207-69-8Relevant articles and documents

Design, synthesis and biological research of novel N-phenylbenzamide-4-methylamine acridine derivatives as potential topoisomerase I/II and apoptosis-inducing agents

Zhang, Bin,Dou, Zhende,Xiong, Zheng,Wang, Ning,He, Shan,Yan, Xiaojun,Jin, Haixiao

, (2019)

A series of novel N-phenylbenzamide-4-methylamine acridine derivatives were designed and synthesized based initially on the structure of amsacrine (m-AMSA). Molecular docking suggested that the representative compound 9a had affinity for binding DNA topoisomerase (Topo) II, which was comparable with that of m-AMSA, and furthermore that 9a could have preferential interactions with Topo I. After synthesis of 9a and analogues 9b-9f, these were all tested in vitro and the synthesized compounds displayed potent antiproliferative activity against three different cancer cell lines (K562, CCRF-CEM and U937). Among them, compounds 9b, 9c and 9d exhibiting the highest activity with IC50 value ranging from 0.82 to 0.91 μM against CCRF-CEM cells. In addition, 9b and 9d also showed high antiproliferative activity against U937 cells, with IC50 values of 0.33 and 0.23 μM, respectively. The pharmacological mechanistic studies of these compounds were evaluated by Topo I/II inhibition, western blot assay and cell apoptosis detection. In summary, 9b effectively inhibited the activity of Topo I/II and induced DNA damage in CCRF-CEM cells and, moreover, significantly induced cell apoptosis in a concentration-dependent manner. These observations provide new information and guidance for the structural optimization of more novel acridine derivatives.

DNA Adduct Detection after Post-Labeling Technique with PCR Amplification (DNA-ADAPT–qPCR) Identifies the Pre-ribosomal RNA Gene as a Direct Target of Platinum–Acridine Anticancer Agents

Yao, Xiyuan,Bierbach, Ulrich

, p. 14681 - 14689 (2021)

To study the DNA damage caused by a potent platinum–acridine anticancer agent (PA) in cancer cells, an assay based on biorthogonal post-labeling using a click chemistry-enabled, azide-modified derivative (APA) was developed. The method involves biotinylation, affinity capture, and bead-based enrichment of APA-modified genomic DNA. The key steps of the assay were validated and optimized in model duplexes, including full-length plasmids, restriction fragments, and a DNA ladder. Native DNA treated with APA and subsequently subjected to post-labeling with a biotin affinity tag was enzymatically digested and fragments were analyzed by in-line LC–MS and MS/MS. The monofunctional–intercalative adducts formed by APA in 5′-pyrimidine/guanine sequences in double-stranded DNA were quantitatively biotinylated by strain-promoted 1,3-dipolar cycloaddition chemistry. When applied to DNA extracted from A549 lung cancer cells, the assay in combination with qPCR amplification demonstrates that platinum–acridines form adducts in the gene sequences encoding pre-ribosomal RNA, a potential pharmacological target of these agents.

-

Ning et al.

, p. 3406 (1976)

-

Formation and molecular structure of the novel acridine substituted uracil derivatives

Kimura,Okabayashi

, p. 965 - 967 (1986)

-

Effects of the Distance between Radical Sites on the Reactivities of Aromatic Biradicals

Ding, Duanchen,Jiang, Hanning,Ma, Xin,Nash, John J.,Kentt?maa, Hilkka I.

, p. 8415 - 8428 (2020)

Coupling of the radical sites in isomeric benzynes is known to hinder their radical reactivity. In order to determine how far apart the radical sites must be for them not to interact, the gas-phase reactivity of several isomeric protonated (iso)quinoline-and acridine-based biradicals was examined. All the (iso)quinolinium-based biradicals were found to react slower than the related monoradicals with similar vertical electron affinities (i.e., similar polar effects). In sharp contrast, the acridinium-based biradicals, most with the radical sites farther apart than in the (iso)quinolinium-based systems, showed greater reactivities than the relevant monoradicals with similar vertical electron affinities. The greater distances between the two radical sites in these biradicals lead to very little or no spin-spin coupling, and no suppression of radical reactivity was observed. Therefore, the radical sites can still interact if they are located on adjacent benzene rings and only after being separated further than that does no coupling occur. The most reactive radical site of each biradical was experimentally determined to be the one predicted to be more reactive based on the monoradical reactivity data. Therefore, the calculated vertical electron affinities of relevant monoradicals can be used to predict which radical site is most reactive in the biradicals.

Novel 9-(2-(1-arylethylidene)hydrazinyl)acridine derivatives: Target Topoisomerase 1 and growth inhibition of HeLa cancer cells

Haider, Md Rafi,Ahmad, Kamal,Siddiqui, Nadeem,Ali, Zulphikar,Akhtar, Md Jawaid,Fuloria, Neeraj,Fuloria, Shivkanya,Ravichandran, Manickam,Yar, M. Shahar

, (2019)

A series of 9-(2-(1-arylethylidene)hydrazinyl)acridine and its analogs were designed, synthesized and evaluated for biological activities. Various biochemical assays were performed to determine the free radical scavenging capacity of synthesized compounds (4a–4j). Anticancer activity of these compounds was assessed against two different human cancer cell lines viz cervical cancer cells (HeLa)and liver cancer cells (HepG2)as well as normal human embryonic kidney cell line (HEK 293). Compounds 4b, 4d and 4e showed potential anti-proliferative effects on HeLa cells. Based on results obtained from antioxidant and cytotoxicity studies, 4b, 4d and 4e were further studied in detail for different biological activities. 4b, 4d and 4e reduced the cell growth, inhibited metastatic activity and declined the potential of cell migration in HeLa cell lines. Topoisomerase1 (Top1)treated with compounds 4b, 4d and 4e exhibited inhibition of Top1 and prevented DNA replication. Molecular docking results validate that interaction of compounds 4b, 4d and 4e with Top1-DNA complex, which might be accountable for their inhibitory effects. Further it was concluded that compounds 4b, 4d and 4e arrests the cells at S phase and consequently induces cell death through DNA damage in HeLa cells.

Novel synthetic acridine-based derivatives as topoisomerase i inhibitors

Li, Bin,Gao, Chun-Mei,Sun, Qin-Sheng,Li, Lu-Lu,Tan, Chun-Yan,Liu, Hong-Xia,Jiang, Yu-Yang

, p. 1021 - 1024 (2014)

Novel DNA binding agents against topoisomerases are needed for effective treatment of cancers. A series of new acridine-based derivatives 7a-7d were synthesized and their antiproliferative activity against K562 and HepG-2 cell lines were evaluated. Compound 7c with pyridin-2-yl-methanamino group substituted at the C9 position of acridine showed good antitumor activity against both cell lines. The DNA-binding affinity of compound 7c was evaluated by UV-vis absorption spectra and fluorescence emission spectra. DNA topoisomerase I mediated relaxation of plasmid pBR322 DNA was also tested. Our results suggested that compound 7c with good antitumor activity and topoisomerase I inhibition activity can be developed as a prime candidate for further chemical optimization.

Design, synthesis and biological evaluation of 4-amidobenzimidazole acridine derivatives as dual PARP and Topo inhibitors for cancer therapy

Yuan, Zigao,Chen, Shaopeng,Chen, Changjun,Chen, Jiwei,Chen, Chengken,Dai, Qiuzi,Gao, Chunmei,Jiang, Yuyang

, p. 1135 - 1146 (2017)

PARP-1 could repair the DNA damages induced by Topo inhibitors, therefore inhibiting Topo and PARP-1 simultaneously might be able to overcome resistance and improve outcomes. In this study a series of 4-amidobenzimidazole acridines were designed and synthesized as dual Topo and PARP-1 inhibitors. Compound 11l displayed good inhibitory activities against Topo and PARP-1, as well as significantly inhibited cancer cells proliferation. Further mechanistic evaluations indicated that 11l treatment in MCF-7 cells induced accumulated DNA double-strand breaks, prompted remarkable apoptosis, and caused prominent G0/G1 cell cycle arrest. Moreover, 11l greatly suppressed tumor growth in mice, and displayed favorable metabolic properties in liver microsomes. Our study suggested that single agents inhibiting Topo and PARP concurrently might be an alternative for cancer therapy and 11l represented a potential lead compound for development of antitumor agents.

Deaminative chlorination of aminoheterocycles

Ghiazza, Clément,Faber, Teresa,Gómez-Palomino, Alejandro,Cornella, Josep

, p. 78 - 84 (2021/12/23)

Selective modification of heteroatom-containing aromatic structures is in high demand as it permits rapid evaluation of molecular complexity in advanced intermediates. Inspired by the selectivity of deaminases in nature, herein we present a simple methodology that enables the NH2 groups in aminoheterocycles to be conceived as masked modification handles. With the aid of a simple pyrylium reagent and a cheap chloride source, C(sp2)?NH2 can be converted into C(sp2)?Cl bonds. The method is characterized by its wide functional group tolerance and substrate scope, allowing the modification of >20 different classes of heteroaromatic motifs (five- and six-membered heterocycles), bearing numerous sensitive motifs. The facile conversion of NH2 into Cl in a late-stage fashion enables practitioners to apply Sandmeyer- and Vilsmeier-type transforms without the burden of explosive and unsafe diazonium salts, stoichiometric transition metals or highly oxidizing and unselective chlorinating agents. [Figure not available: see fulltext.]

Synthesis and performance research of selenazole fluorescent dye compound

-

Paragraph 0007; 0017, (2020/02/27)

The invention discloses synthesis and performance research of a selenazole fluorescent dye compound; benzoselenazole is used as a recognition group for detecting the HOCl level in cells, and a reliable method is provided for detecting the HOCl level in a biological system in real time. A probe disclosed by the invention has the technical effects that the probe can sensitively and selectively respond to HOCl and detect the HOCl level in tumor living cells, so that the HOCl level in the tumor living cells can be rapidly monitored, and a new method can be provided for early detection of tumors. Compared with other fluorescent compounds, the fluorescent reaction system containing the selenide functional group is simple, has the characteristics of high luminous efficiency, small background interference and the like, and is a fluorescent probe with a wide prospect.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1207-69-8